EGFR and metastatic neoplasm: The majority of discordant cases concerned surgery (12.3%), radiotherapy (16.7%), and chemoradiotherapy (11.6%), but not patients with metastatic disease (0%) [414], while it remained unclear whether EGFR status or immunotherapy affected concordance [415,416,417].